Literature DB >> 20881235

Role of calcium-phosphate deposition in vascular smooth muscle cell calcification.

Ricardo Villa-Bellosta1, Angel Millan, Víctor Sorribas.   

Abstract

In this work we are studying whether calcium phosphate deposition (CPD) during vascular calcification is a passive or a cell-mediated mechanism. Passive CPD was studied in fixed vascular smooth muscle cells (VSMC), which calcify faster than live cells in the presence of 1.8 mM Ca²(+) and 2 mM P(i). CPD seems to be a cell-independent process that depends on the concentration of calcium, phosphate, and hydroxyl ions, but not on Ca × P(i) concentration products, given that deposition is obtained with 2 × 2 and 4 × 1 Ca × P(i) mM² but not with 2 × 1 or 1 × 4 Ca × P(i) mM². Incubation with 4 mM P(i) without CPD (i.e., plus 1 mM Ca) does not induce osteogene expression. Increased expression of bone markers such as Bmp2 and Cbfa1 is only observed concomitantly with CPD. Hydroxyapatite is the only crystalline phase in both lysed and live cells. Lysed cell deposits are highly crystalline, whereas live cell deposits still contain large amounts of amorphous calcium. High-resolution transmission electron microscopy revealed a nanostructure of rounded crystallites of 5-10 nm oriented at random in lysed cells, which is compatible with spontaneous precipitation. The nanostructure in live cells consisted of long fiber crystals, 10-nm thick, embedded in an amorphous matrix. This structure indicates an active role of cells in the process of hydroxyapatite crystallization. In conclusion, our data suggest that CPD is a passive phenomenon, which triggers the osteogenic changes that are involved in the formation of a well organized, calcified crystalline structure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20881235     DOI: 10.1152/ajpcell.00229.2010

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  54 in total

1.  Zinc Inhibits Phosphate-Induced Vascular Calcification through TNFAIP3-Mediated Suppression of NF-κB.

Authors:  Jakob Voelkl; Rashad Tuffaha; Trang T D Luong; Daniel Zickler; Jaber Masyout; Martina Feger; Nicolas Verheyen; Florian Blaschke; Makoto Kuro-O; Andreas Tomaschitz; Stefan Pilz; Andreas Pasch; Kai-Uwe Eckardt; Juergen E Scherberich; Florian Lang; Burkert Pieske; Ioana Alesutan
Journal:  J Am Soc Nephrol       Date:  2018-04-13       Impact factor: 10.121

Review 2.  Arterial calcification in chronic kidney disease: key roles for calcium and phosphate.

Authors:  Catherine M Shanahan; Matthew H Crouthamel; Alexander Kapustin; Cecilia M Giachelli
Journal:  Circ Res       Date:  2011-09-02       Impact factor: 17.367

Review 3.  Chronic kidney disease as a coronary artery disease risk equivalent.

Authors:  Alexandrios Briasoulis; George L Bakris
Journal:  Curr Cardiol Rep       Date:  2013-03       Impact factor: 2.931

4.  Hydroxyapatite and calcified elastin induce osteoblast-like differentiation in rat aortic smooth muscle cells.

Authors:  Yang Lei; Aditi Sinha; Nasim Nosoudi; Ankit Grover; Naren Vyavahare
Journal:  Exp Cell Res       Date:  2014-01-18       Impact factor: 3.905

5.  Nano-hydroxyapatite modulates osteoblast lineage commitment by stimulation of DNA methylation and regulation of gene expression.

Authors:  Shin-Woo Ha; Hae Lin Jang; Ki Tae Nam; George R Beck
Journal:  Biomaterials       Date:  2015-06-23       Impact factor: 12.479

6.  Systems biology identifies cytosolic PLA2 as a target in vascular calcification treatment.

Authors:  Joost P Schanstra; Trang Td Luong; Manousos Makridakis; Sophie Van Linthout; Vasiliki Lygirou; Agnieszka Latosinska; Ioana Alesutan; Beate Boehme; Nadeshda Schelski; Dirk Von Lewinski; William Mullen; Stuart Nicklin; Christian Delles; Guylène Feuillet; Colette Denis; Florian Lang; Burkert Pieske; Jean-Loup Bascands; Harald Mischak; Jean-Sebastien Saulnier-Blache; Jakob Voelkl; Antonia Vlahou; Julie Klein
Journal:  JCI Insight       Date:  2019-05-16

7.  Size-Dependent Cytotoxicity of Hydroxyapatite Crystals on Renal Epithelial Cells.

Authors:  Xin-Yuan Sun; Jia-Yun Chen; Chen-Ying Rao; Jian-Ming Ouyang
Journal:  Int J Nanomedicine       Date:  2020-07-15

Review 8.  Regulatory circuits controlling vascular cell calcification.

Authors:  Tamer Sallam; Henry Cheng; Linda L Demer; Yin Tintut
Journal:  Cell Mol Life Sci       Date:  2012-12-27       Impact factor: 9.261

9.  The relationship between vascular calcifications and urolithiasis in a large, multiethnic patient population.

Authors:  Daniel Schoenfeld; Denzel Zhu; Ilir Agalliu; Joshua M Stern; Larkin Mohn; Joseph Di Vito
Journal:  Urolithiasis       Date:  2021-05-07       Impact factor: 3.436

Review 10.  Multiple Pathways for Pathological Calcification in the Human Body.

Authors:  Netta Vidavsky; Jennie A M R Kunitake; Lara A Estroff
Journal:  Adv Healthc Mater       Date:  2020-12-04       Impact factor: 9.933

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.